Market report
Pharmaceutical tenders in Czechia — market report, April 2026
Pharmaceutical tenders in Czechia in April 2026: 9,260 tenders published (-4% month on month, -3% year on year), estimated at €58,001,164 in total, and 9,398 contracts awarded (-5% month on month, -4% year on year), worth €727,587,209 (awarded value). Buyers with the most tenders: Fakultní nemocnice Brno (880), Fakultní nemocnice Olomouc (829) and Krajská zdravotní, a.s. (804); most contracts won: ROCHE s.r.o. (223), Takeda Pharmaceuticals Czech Republic s.r.o. (211) and Janssen-Cilag s.r.o. (178). On average 4.4 bids per contract; 52% of contracts had a single bid. Report made on 27 October 2026.
- Tenders published
- 9,260
- Contracts awarded
- 9,398
- Contract value awarded
- €727,587,209
- Bids per contract
- 4.4
The highlighted bar is April 2026. Hover a bar for its figure; the table below has every value.
| Figure | April 2026 | March 2026 | Change | April 2025 | Change |
|---|---|---|---|---|---|
| Tenders published | 9,260 | 9,679 | -4% | 9,546 | -3% |
| Estimated value | €58,001,164 | €844,673,398 | -93% | €58,656,007 | -1% |
| Buyers | 88 | 89 | -1% | 90 | -2% |
| Contracts awarded | 9,398 | 9,848 | -5% | 9,774 | -4% |
| Contract value (awarded) | €727,587,209 | €102,682,693 | +609% | €156,772,094 | +364% |
| Winners | 423 | 434 | -3% | 343 | +23% |
| Bids per contract | 4.4 | 14.9 | — | 2.6 | — |
| Single-bid contracts | 52% | 45% | — | 60% | — |
Buyers with the most tenders
Companies with the most contracts
| # | Winners | Contracts |
|---|---|---|
| 1 | ROCHE s.r.o. | 223 |
| 2 | Takeda Pharmaceuticals Czech Republic s.r.o. | 211 |
| 3 | Janssen-Cilag s.r.o. | 178 |
| 4 | ViaPharma s.r.o. | 175 |
| 5 | AbbVie s.r.o. | 170 |
| 6 | Amgen s.r.o. | 149 |
| 7 | Avenier a.s. | 122 |
| 8 | BAYER s.r.o. | 121 |
| 9 | Gilead Sciences s.r.o. | 116 |
| 10 | ELI LILLY ČR, s.r.o. | 101 |
Where the tenders were
Procedures
The report's aggregates: the figures, the comparisons and the top lists by name and count.
All reports: Medicines and pharmaceuticals
Questions and answers
- How many pharmaceutical tenders were published in Czechia in April 2026?
- 9,260 (by 88 buyers); for comparison, March 2026: 9,679, April 2025: 9,546.
- Who won the most pharmaceutical tenders in Czechia in April 2026?
- By number of contracts: ROCHE s.r.o. (223), Takeda Pharmaceuticals Czech Republic s.r.o. (211), Janssen-Cilag s.r.o. (178), ViaPharma s.r.o. (175) and AbbVie s.r.o. (170); 423 companies won contracts in all.
- Which buyers published the most pharmaceutical tenders in April 2026?
- Fakultní nemocnice Brno (880), Fakultní nemocnice Olomouc (829), Krajská zdravotní, a.s. (804), Institut klinické a experimentální medicíny (795) and Fakultní nemocnice Bulovka (580).
- How competitive were pharmaceutical tenders in Czechia in April 2026?
- On average 4.4 bids per contract (214 contracts with a known number of bids); 52% of contracts had a single bid.
- What were the contracts worth in April 2026?
- €727,587,209 (awarded value, 9,398 contracts); median about €390,000.
How the report is made
Tenders published: the tenders of the sector or topic whose first notice is dated in the month (a tender counts in its sector and in up to three topics). Contracts awarded: the awards dated in the month, whenever their tender was published. Values in EUR, by value kind (never added together); medians are approximate (±3 %). Comparisons: with the reports of the previous month and of the same month a year earlier, each made the same way. The report was made on 27 October 2026 from the data of that day and is not changed afterwards; sources publish late, so later data for the month are not in it.